Actively Recruiting
Development Of a Virtual Stress Inoculation Training (SIT) Platform and Mobile Health App
Led by The University of Texas Health Science Center, Houston · Updated on 2024-07-10
20
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to demonstrate the feasibility and utility of SIT delivered asynchronously (self-paced) via fully virtual platform with and without the aid of a mobile health application and to determine initial change over baseline in terms of reduction in PTSD symptoms and improvement in resiliency in participants receiving the virtual SIT prototype, using Linear Mixed Models (LMMs),
CONDITIONS
Official Title
Development Of a Virtual Stress Inoculation Training (SIT) Platform and Mobile Health App
Who Can Participate
Eligibility Criteria
You may qualify if you...
- US Military Veterans or Service Members
- Diagnosis of PTSD with a Posttraumatic Symptom Checklist for DSM-5 (PCL-5) score greater than 33
- History of combat trauma and/or military service in an imminent danger pay area
- Fluent in English
- Capable of giving signed informed consent and complying with study requirements
- Access to a smartphone or tablet to use the mobile health app and/or virtual classroom
- Agree to psychometric testing and participate in ongoing assessments throughout the study
- Willing and able to complete all assessments independently and available for the study duration
You will not qualify if you...
- Active suicidal ideation as assessed by the investigator at screening or during the study
- Clinically significant history of psychotic disorder, bipolar spectrum disorder, or neurodegenerative disease/dementia
- Active severe substance abuse as defined by DSM-5 criteria, AUDIT score over 15, or illicit substance use other than cannabis more than 3 times weekly
- Currently receiving treatments other than supportive therapy more than twice per month
- Engaged in active trauma-focused therapy including Cognitive Processing Therapy, Prolonged Exposure, or Eye Movement Desensitization and Reprocessing
- Any condition or situation that the investigator believes may interfere with participant safety, study conduct, or interpretation of data
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
S
Sarah Jackson, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here